+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breakthrough Therapies"

Drugs for Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Drugs for Immunotherapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Melanoma Drugs Global Market Report 2024 - Product Thumbnail Image

Melanoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
AXS-05 - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

AXS-05 - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 30 Pages
  • Global
From
From
bb2121 - Product Thumbnail Image

bb2121

  • Report
  • August 2018
  • 20 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Breakthrough Therapies are a type of pharmaceutical drug that has been developed to treat serious or life-threatening diseases. These drugs are typically developed using innovative technologies and have the potential to provide substantial improvements in the safety and effectiveness of treatments. Breakthrough Therapies are typically developed to treat conditions that have not responded to existing treatments, or to provide treatments for conditions that have no existing treatments. Breakthrough Therapies are typically developed through a rigorous process of clinical trials and regulatory approval. This process is designed to ensure that the drug is safe and effective for its intended use. Once approved, Breakthrough Therapies are typically made available to patients through prescription. Some companies in the Breakthrough Therapies market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more